drugset / Trial / NCT05278858

Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata

NCT05278858

Phase 4 Terminated 3 enrolled University Hospitals Cleveland Medical Center
NaSingle-groupOpen-labelOther

Summary

This is an interventional pilot study assessing the tolerability of needle-free delivery administration of ILTA with the Med-Jet as an alternative to conventional syringe and needle in patients with patchy pediatric alopecia areata. There will be a total of four (4) or five (5) visits necessary for study participation. The investigators hypothesize that the Med-Jet will have acceptable pain tolerability, efficacy, safety, and a positive impact on patient quality of life.

Timeline

Start
2022-03-24
Primary completion
2023-06-06
Completion
2023-06-06

Drugs

EvaluationDrugModalityDoseRoute
Background Triamcinolone Other / unclassified 10 mg/ml Other

Indications